United States - English - NLM (National Library of Medicine)

modlina cosmetics co., ltd - p-aminophenol (unii: r7p8frp05v) (p-aminophenol - unii:r7p8frp05v) - p-aminophenol 0.01 mg in 1 ml - hair coloring please mix hair dye a and hair dye b uniformly at 1:1 ratio（a special mixer was contained in the package） uniformly daub the hair with the mixed hair dye. keep for 7-10min，rinse thoroughly with water，ensure without residual hair dye. daub the hair with the contained hair conditioner and rinse thoroughly with water. （hair dye dosage used in the dyeing process according to the hair length

United States - English - NLM (National Library of Medicine)

remedyrepack inc. - darunavir ethanolate (unii: 33o78xf0bw) (darunavir - unii:yo603y8113) - darunavir 600 mg - prezista ® , co-administered with ritonavir (prezista/ritonavir), in combination with other antiretroviral agents, is indicated for the treatment of human immunodeficiency virus (hiv-1) infection in adult and pediatric patients 3 years of age and older [see use in specific populations (8.4) and clinical studies (14)] . co-administration of prezista/ritonavir is contraindicated with drugs that are highly dependent on cyp3a for clearance and for which elevated plasma concentrations are associated with serious and/or life-threatening events (narrow therapeutic index). these drugs and other contraindicated drugs (which may lead to reduced efficacy of darunavir) are listed in table 6 . due to the need for co-administration of prezista with ritonavir, please refer to ritonavir prescribing information for a description of ritonavir contraindications. co-administration of prezista/ritonavir is contraindicated with drugs that are highly dependent on cyp3a for clearance and for which elevated plasma concentrations are

United States - English - NLM (National Library of Medicine)

avera mckennan hospital - darunavir ethanolate (unii: 33o78xf0bw) (darunavir - unii:yo603y8113) - darunavir 800 mg

United States - English - NLM (National Library of Medicine)

avion pharmaceuticals, llc - sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5) - sulfacetamide sodium 100 mg in 1 g

United States - English - NLM (National Library of Medicine)

exact-rx, inc. - sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5), sulfur (unii: 70fd1kfu70) (sulfur - unii:70fd1kfu70) - sulfacetamide sodium 100 mg in 1 g - indications: sodium sulfacetamide 10% & sulfur 5% cleanser is indicated in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis. contraindications: sodium sulfacetamide 10% & sulfur 5% cleanser is contraindicated for use by patients having known hypersensitivity to sulfonamides, sulfur or any other component of this preparation. sodium sulfacetamide 10% & sulfur 5% cleanser is not to be used by patients with kidney disease. pediatric use: safety and effectiveness in children under the age of 12 years have not been established.

United States - English - NLM (National Library of Medicine)

galderma laboratories, l.p. - sulfacetamide (unii: 4965g3j0f5) (sulfacetamide - unii:4965g3j0f5), sulfur (unii: 70fd1kfu70) (sulfur - unii:70fd1kfu70) - sulfacetamide 10 g in 100 g - rosanil® cleanser is indicated in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis. rosanil® cleanser is contraindicated for use by patients having known hypersensitivity to sulfonamides, sulfur or any other component of this preparation. rosanil® cleanser is not to be used by patients with kidney disease.

United States - English - NLM (National Library of Medicine)

a-s medication solutions - darunavir ethanolate (unii: 33o78xf0bw) (darunavir - unii:yo603y8113) - darunavir 800 mg - prezista® , co-administered with ritonavir (prezista/ritonavir), in combination with other antiretroviral agents, is indicated for the treatment of human immunodeficiency virus (hiv-1) infection in adult and pediatric patients 3 years of age and older [see use in specific populations (8.4) and clinical studies (14)] . co-administration of prezista/ritonavir is contraindicated with drugs that are highly dependent on cyp3a for clearance and for which elevated plasma concentrations are associated with serious and/or life-threatening events (narrow therapeutic index). these drugs and other contraindicated drugs (which may lead to reduced efficacy of darunavir) are listed below [see drug interactions (7.3)] . due to the need for co-administration of prezista with ritonavir, please refer to ritonavir prescribing information for a description of ritonavir contraindications. - alpha 1-adrenoreceptor antagonist: alfuzosin - antianginal: ranolazine - antiarrhythmic: dronedarone - anti-gout: colchicine, in patients

United States - English - NLM (National Library of Medicine)

remedyrepack inc. - darunavir ethanolate (unii: 33o78xf0bw) (darunavir - unii:yo603y8113) - darunavir 800 mg

Canada - English - Health Canada

avir pharma inc. - mesalazine - suppository - 1g - mesalazine 1g - anti-inflammatory agents

Canada - English - Health Canada

avir pharma inc. - mesalazine - foam - 1g - mesalazine 1g - anti-inflammatory agents